Similarly, Cesarini et al. demonstrated that in glioblastoma, it is not the ADAR2 transcript level but rather the protein abundance that correlates with patient survival, with higher ADAR2 expression being particularly associated with prolonged overall survival [66]. Here, ADARB1 is linked to glioblastoma.